‘Absolutely staggering’: Results from experimental drug trial to prevent Parkinson’s disease

AI Summary

An Australian-led experimental drug trial found evidence that a treatment may reduce brain inflammation in people at high risk of Parkinson’s disease. Researchers say the findings could point to a way to slow or prevent the disease, though the results are preliminary.

For the first time, the Australian-led trial has found evidence that an experimental drug could lessen inflammation in the brains of people at high risk of Parkinson’s, potentially slowing or even stopping its development.